Global Raynauds Disease Treatment Market Research Report 2024

Report ID: 1977405 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Raynauds Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Acetylcysteine
        1.2.3 Alprostadil
        1.2.4 ELS-140
        1.2.5 Neovasculgen
        1.2.6 Nitroglycerin
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Raynauds Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Raynauds Disease Treatment Market Perspective (2018-2029)
    2.2 Raynauds Disease Treatment Growth Trends by Region
        2.2.1 Global Raynauds Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Raynauds Disease Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Raynauds Disease Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Raynauds Disease Treatment Market Dynamics
        2.3.1 Raynauds Disease Treatment Industry Trends
        2.3.2 Raynauds Disease Treatment Market Drivers
        2.3.3 Raynauds Disease Treatment Market Challenges
        2.3.4 Raynauds Disease Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Raynauds Disease Treatment Players by Revenue
        3.1.1 Global Top Raynauds Disease Treatment Players by Revenue (2018-2023)
        3.1.2 Global Raynauds Disease Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Raynauds Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Raynauds Disease Treatment Revenue
    3.4 Global Raynauds Disease Treatment Market Concentration Ratio
        3.4.1 Global Raynauds Disease Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Raynauds Disease Treatment Revenue in 2022
    3.5 Raynauds Disease Treatment Key Players Head office and Area Served
    3.6 Key Players Raynauds Disease Treatment Product Solution and Service
    3.7 Date of Enter into Raynauds Disease Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Raynauds Disease Treatment Breakdown Data by Type
    4.1 Global Raynauds Disease Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Raynauds Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Raynauds Disease Treatment Breakdown Data by Application
    5.1 Global Raynauds Disease Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Raynauds Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Raynauds Disease Treatment Market Size (2018-2029)
    6.2 North America Raynauds Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Raynauds Disease Treatment Market Size by Country (2018-2023)
    6.4 North America Raynauds Disease Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Raynauds Disease Treatment Market Size (2018-2029)
    7.2 Europe Raynauds Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Raynauds Disease Treatment Market Size by Country (2018-2023)
    7.4 Europe Raynauds Disease Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Raynauds Disease Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Raynauds Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Raynauds Disease Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Raynauds Disease Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Raynauds Disease Treatment Market Size (2018-2029)
    9.2 Latin America Raynauds Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Raynauds Disease Treatment Market Size by Country (2018-2023)
    9.4 Latin America Raynauds Disease Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Raynauds Disease Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Raynauds Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Raynauds Disease Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Raynauds Disease Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Allergan Plc
        11.1.1 Allergan Plc Company Detail
        11.1.2 Allergan Plc Business Overview
        11.1.3 Allergan Plc Raynauds Disease Treatment Introduction
        11.1.4 Allergan Plc Revenue in Raynauds Disease Treatment Business (2018-2023)
        11.1.5 Allergan Plc Recent Development
    11.2 Apricus Biosciences, Inc.
        11.2.1 Apricus Biosciences, Inc. Company Detail
        11.2.2 Apricus Biosciences, Inc. Business Overview
        11.2.3 Apricus Biosciences, Inc. Raynauds Disease Treatment Introduction
        11.2.4 Apricus Biosciences, Inc. Revenue in Raynauds Disease Treatment Business (2018-2023)
        11.2.5 Apricus Biosciences, Inc. Recent Development
    11.3 Bayer AG
        11.3.1 Bayer AG Company Detail
        11.3.2 Bayer AG Business Overview
        11.3.3 Bayer AG Raynauds Disease Treatment Introduction
        11.3.4 Bayer AG Revenue in Raynauds Disease Treatment Business (2018-2023)
        11.3.5 Bayer AG Recent Development
    11.4 Covis Pharmaceuticals, Inc.
        11.4.1 Covis Pharmaceuticals, Inc. Company Detail
        11.4.2 Covis Pharmaceuticals, Inc. Business Overview
        11.4.3 Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Introduction
        11.4.4 Covis Pharmaceuticals, Inc. Revenue in Raynauds Disease Treatment Business (2018-2023)
        11.4.5 Covis Pharmaceuticals, Inc. Recent Development
    11.5 Human Stem Cells Institute
        11.5.1 Human Stem Cells Institute Company Detail
        11.5.2 Human Stem Cells Institute Business Overview
        11.5.3 Human Stem Cells Institute Raynauds Disease Treatment Introduction
        11.5.4 Human Stem Cells Institute Revenue in Raynauds Disease Treatment Business (2018-2023)
        11.5.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Raynauds Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Acetylcysteine
    Table 3. Key Players of Alprostadil
    Table 4. Key Players of ELS-140
    Table 5. Key Players of Neovasculgen
    Table 6. Key Players of Nitroglycerin
    Table 7. Key Players of Others
    Table 8. Global Raynauds Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Raynauds Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Raynauds Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Raynauds Disease Treatment Market Share by Region (2018-2023)
    Table 12. Global Raynauds Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Raynauds Disease Treatment Market Share by Region (2024-2029)
    Table 14. Raynauds Disease Treatment Market Trends
    Table 15. Raynauds Disease Treatment Market Drivers
    Table 16. Raynauds Disease Treatment Market Challenges
    Table 17. Raynauds Disease Treatment Market Restraints
    Table 18. Global Raynauds Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Raynauds Disease Treatment Market Share by Players (2018-2023)
    Table 20. Global Top Raynauds Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Raynauds Disease Treatment as of 2022)
    Table 21. Ranking of Global Top Raynauds Disease Treatment Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Raynauds Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Raynauds Disease Treatment Product Solution and Service
    Table 25. Date of Enter into Raynauds Disease Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Raynauds Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Raynauds Disease Treatment Revenue Market Share by Type (2018-2023)
    Table 29. Global Raynauds Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Raynauds Disease Treatment Revenue Market Share by Type (2024-2029)
    Table 31. Global Raynauds Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Raynauds Disease Treatment Revenue Market Share by Application (2018-2023)
    Table 33. Global Raynauds Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Raynauds Disease Treatment Revenue Market Share by Application (2024-2029)
    Table 35. North America Raynauds Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Raynauds Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Raynauds Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Raynauds Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Raynauds Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Raynauds Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Raynauds Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Raynauds Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Raynauds Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Raynauds Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Raynauds Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Raynauds Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Raynauds Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Raynauds Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Raynauds Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Allergan Plc Company Detail
    Table 51. Allergan Plc Business Overview
    Table 52. Allergan Plc Raynauds Disease Treatment Product
    Table 53. Allergan Plc Revenue in Raynauds Disease Treatment Business (2018-2023) & (US$ Million)
    Table 54. Allergan Plc Recent Development
    Table 55. Apricus Biosciences, Inc. Company Detail
    Table 56. Apricus Biosciences, Inc. Business Overview
    Table 57. Apricus Biosciences, Inc. Raynauds Disease Treatment Product
    Table 58. Apricus Biosciences, Inc. Revenue in Raynauds Disease Treatment Business (2018-2023) & (US$ Million)
    Table 59. Apricus Biosciences, Inc. Recent Development
    Table 60. Bayer AG Company Detail
    Table 61. Bayer AG Business Overview
    Table 62. Bayer AG Raynauds Disease Treatment Product
    Table 63. Bayer AG Revenue in Raynauds Disease Treatment Business (2018-2023) & (US$ Million)
    Table 64. Bayer AG Recent Development
    Table 65. Covis Pharmaceuticals, Inc. Company Detail
    Table 66. Covis Pharmaceuticals, Inc. Business Overview
    Table 67. Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Product
    Table 68. Covis Pharmaceuticals, Inc. Revenue in Raynauds Disease Treatment Business (2018-2023) & (US$ Million)
    Table 69. Covis Pharmaceuticals, Inc. Recent Development
    Table 70. Human Stem Cells Institute Company Detail
    Table 71. Human Stem Cells Institute Business Overview
    Table 72. Human Stem Cells Institute Raynauds Disease Treatment Product
    Table 73. Human Stem Cells Institute Revenue in Raynauds Disease Treatment Business (2018-2023) & (US$ Million)
    Table 74. Human Stem Cells Institute Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Raynauds Disease Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Raynauds Disease Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Acetylcysteine Features
    Figure 4. Alprostadil Features
    Figure 5. ELS-140 Features
    Figure 6. Neovasculgen Features
    Figure 7. Nitroglycerin Features
    Figure 8. Others Features
    Figure 9. Global Raynauds Disease Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Raynauds Disease Treatment Market Share by Application: 2022 VS 2029
    Figure 11. Hospital Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Others Case Studies
    Figure 14. Raynauds Disease Treatment Report Years Considered
    Figure 15. Global Raynauds Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Raynauds Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Raynauds Disease Treatment Market Share by Region: 2022 VS 2029
    Figure 18. Global Raynauds Disease Treatment Market Share by Players in 2022
    Figure 19. Global Top Raynauds Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Raynauds Disease Treatment as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Raynauds Disease Treatment Revenue in 2022
    Figure 21. North America Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Raynauds Disease Treatment Market Share by Country (2018-2029)
    Figure 23. United States Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Raynauds Disease Treatment Market Share by Country (2018-2029)
    Figure 27. Germany Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Raynauds Disease Treatment Market Share by Region (2018-2029)
    Figure 35. China Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Raynauds Disease Treatment Market Share by Country (2018-2029)
    Figure 43. Mexico Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Raynauds Disease Treatment Market Share by Country (2018-2029)
    Figure 47. Turkey Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Raynauds Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Allergan Plc Revenue Growth Rate in Raynauds Disease Treatment Business (2018-2023)
    Figure 50. Apricus Biosciences, Inc. Revenue Growth Rate in Raynauds Disease Treatment Business (2018-2023)
    Figure 51. Bayer AG Revenue Growth Rate in Raynauds Disease Treatment Business (2018-2023)
    Figure 52. Covis Pharmaceuticals, Inc. Revenue Growth Rate in Raynauds Disease Treatment Business (2018-2023)
    Figure 53. Human Stem Cells Institute Revenue Growth Rate in Raynauds Disease Treatment Business (2018-2023)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan Plc
Apricus Biosciences, Inc.
Bayer AG
Covis Pharmaceuticals, Inc.
Human Stem Cells Institute
Frequently Asked Questions
Raynauds Disease Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Raynauds Disease Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Raynauds Disease Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Abbe Refractometers

This report aims to provide a comprehensive presentation of the global market for Abbe Refractome ... Read More